Improved Cardiovascular Disease Outcomes in Older Adults.

Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care. Br J Gen Pract (2016) 0.75

Geriatric cardiology and the Great Wall International Congress of Cardiology 2015. J Geriatr Cardiol (2016) 0.75

Sarcopenia in heart failure: mechanisms and therapeutic strategies. J Geriatr Cardiol (2016) 0.75

Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA (2014) 34.12

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99

Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50

Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81

Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med (2013) 20.98

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 16.52

Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70

Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med (2014) 11.77

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet (2007) 10.10

Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA (2004) 9.55

Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet (2013) 7.54

Spironolactone for heart failure with preserved ejection fraction. N Engl J Med (2014) 7.48

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation (2007) 5.89

A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol (2013) 5.04

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation (2014) 4.56

The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med (2015) 3.36

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. J Am Coll Cardiol (2013) 3.06

Outcomes following transcatheter aortic valve replacement in the United States. JAMA (2013) 2.88

ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol (2011) 2.83

Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation. Circulation (2011) 2.60

2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44

(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging (2013) 2.20

Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Europace (2014) 2.08

Geriatric conditions and subsequent mortality in older patients with heart failure. J Am Coll Cardiol (2010) 2.07

Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol (2013) 1.82

Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis. Circulation (2015) 1.66

Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons. Ann Thorac Surg (2011) 1.49

Cumulative incidence of death and rehospitalization among the elderly in the first year after NSTEMI. Am J Med (2015) 1.43

Frailty and the selection of patients for destination therapy left ventricular assist device. Circ Heart Fail (2012) 1.28

Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol (2014) 1.27

Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA (2015) 1.23

Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication. Int J Cardiol (2014) 1.21

Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med (2014) 1.20

Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail (2014) 1.12

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J (2015) 1.08

Potential therapeutic competition in community-living older adults in the U.S.: use of medications that may adversely affect a coexisting condition. PLoS One (2014) 1.08

Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines. J Am Coll Cardiol (2015) 1.07

The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol (2013) 1.04

Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J (2013) 1.03

End-of-life care in patients with heart failure. J Card Fail (2014) 1.00

Musculoskeletal health, frailty and functional decline. Best Pract Res Clin Rheumatol (2014) 1.00

Statins in the elderly: a patient-focused approach. Clin Cardiol (2014) 0.99

Rational dispersion for the introduction of transcatheter valve therapy. JAMA (2011) 0.98

Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes. Circ Heart Fail (2015) 0.95

Survival in elderly patients supported with continuous flow left ventricular assist device as bridge to transplantation or destination therapy. J Card Fail (2014) 0.94

'Hearts and minds': association, causation and implication of cognitive impairment in heart failure. Alzheimers Res Ther (2015) 0.94

Risk factors for falls among seniors: implications of gender. Am J Epidemiol (2015) 0.86

What to Expect From the Evolving Field of Geriatric Cardiology. J Am Coll Cardiol (2015) 0.85

Cardiac amyloidosis: the great pretender. Heart Fail Rev (2015) 0.84

Older Adults' Recognition of Trade-Offs in Healthcare Decision-Making. J Am Geriatr Soc (2015) 0.81

Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Eur Heart J Acute Cardiovasc Care (2015) 0.79

Heart failure management in skilled nursing facilities: a scientific statement from the American Heart Association and the Heart Failure Society of America. J Card Fail (2015) 0.78

Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology. Am J Med (2015) 0.77